Improves Athletic Performance
Originally, the Food and Drug Administration approved semaglutide, better known by its brand name of Ozempic, in 2017 as a treatment for type 2 diabetes
1c) of acid-ethanol extracts of rat gastric and ileal mucosa identified proglucagon, GLP-1, and GLP-2 fragments consistent with PC1/3 cleavage sites after trypsin, Lys-C, chymotrypsin, and Glu-C digestion
Retatrutide is approximately 39 amino acids with specific modifications
95% confidence interval [CI]: 33.6 to 32.2
Results vary depending on skin type, treatment frequency, dosage, and lifestyle habits, and scientific evidence is still limited on their long-term effectiveness